Methods for preventing or treating H. pylori infection
AssigneeTennor Therapeutics (Suzhou) Limited
InventorsZhenkun Ma, Guozhu Geng, Jing Chen, Yu Liu, Xiangyi Xu, Changlin Ai, Junlei Zhang, Ting Song, Shuangshuang Zhao
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods, drug combinations and kits for treating, ameliorating, reversing and/or preventing a Helicobacter pylori (H. pylori) infection in a patient in need thereof.
Claims14
A method for treating, ameliorating, and/or reversing a Helicobacter pylori (H. pylori) infection in a patient in need thereof, comprising administering to said patient:
- an effective amount of compound I 4-Deoxy-3,4-(1H)-imidazo-(2,5-dihydro)rifamycin, or a pharmaceutically acceptable salt thereof;
- an effective amount of an additional antibiotic, and an effective amount of an acid blocker,
- wherein said compound I is administered to said patient at a dose of about 400 mg to about 600 mg, twice per day (BID) or three times per day (TID),
- wherein said compound I is a compound of Formula 2
- wherein an effective amount of said acid blocker is at a dose of about 10 mg to about 20 mg, and said acid blocker is proton pump inhibitor (PPI);
- and,
- wherein an effective amount of said additional antibiotic is twice per day (BID) or three times per day (TID), for 7-14 consecutive days;
- and said additional antibiotic is amoxicillin.
A drug combination, comprising an effective amount of compound I 4-Deoxy-3,4-(1H)-imidazo-(2,5-dihydro)rifamycin, or a pharmaceutically acceptable salt thereof;
- an effective amount of an acid blocker, and an effective amount of an additional antibiotic, wherein said acid blocker is a proton pump inhibitor (PPD), said compound I is a compound of Formula 2
- and
- wherein said additional antibiotic is amoxicillin.
Dependencies are inferred from the claim text.